Epigenetic Control of Hypertension by DNA Methylation: A Real Possibility
- PMID: 33749553
- DOI: 10.2174/1381612827666210322141703
Epigenetic Control of Hypertension by DNA Methylation: A Real Possibility
Abstract
Hypertension is a common chronic disease that particularly affects the elderly and can trigger several cardiovascular conditions. Although the treatment of hypertension has evolved in recent decades, many hypertensive patients still do not have properly controlled blood pressure. Accumulating evidence supports the hypothesis that DNA methylation plays an important role in regulating gene expression, altering the phenotype and function of the cardiovascular system. The present review highlights recent advances in research on DNA methylation in the development of hypertension. Several preclinical and clinical evidence show that methylation of different targets appears to be involved in hypertension. Studies of the involvement of DNA methylation have greatly improved our understanding of hypertension, but its use as a valid therapeutic target is still unknown. Further studies could help to bring to light the truth about gene therapy in hypertension.
Keywords: Blood pressure; cardiovascular disease; chronic disease; drug discovery; epigenomic; gene; phenotype..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Publication types
MeSH terms
Grants and funding
- 59/300.046/2015, 71/700.135/2018/Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT, Brazil)
- 449464/2014-8, 407685/2018-9/Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Brazil)
- 51534.545.50190.19112018/Fundação Araucária (Brazil)
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical